Stay updated on ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial page.

Latest updates to the ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial page
- Check3 days agoChange DetectedA new revision (v3.3.4) was added to the record history and a previous revision (v3.3.3) was removed from the history list.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.3 was added to the page, and the footer now removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. These are minor maintenance updates that do not affect the study information or user actions on the page.SummaryDifference0.2%

- Check52 days agoChange DetectedNew revision label v3.3.2 appears in the page history, and the previous v3.2.0 revision is removed.SummaryDifference0.1%

- Check59 days agoChange DetectedThe notice regarding lapse in government funding and operating status on the NIH site was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check81 days agoChange DetectedA new version entry was added to the Record History, updating the study's recruitment status and study status.SummaryDifference0.1%

- Check102 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference12%

Stay in the know with updates to ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLCAR19 Immunotherapy for B-cell Malignancies Clinical Trial page.